United States · FDA National Drug Code directory
ZYKADIA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0694_8c405b95-6d3c-4bc5-9b01-2feb80903756
- Product NDC
- 0078-0694
- Form
- TABLET, FILM COATED
- Composition / generic term
- ceritinib
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 20190318
- Source listing expiry
- 20261231
Source-listed ingredients
- CERITINIB — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 21 TABLET, FILM COATED in 1 BOTTLE (0078-0694-48) · 0078-0694-48
- 84 TABLET, FILM COATED in 1 BOTTLE (0078-0694-84) · 0078-0694-84
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →